- Home
- HSCS vs NDRA Comparison
HSCS vs NDRA Comparison
Compare HSCS & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- NDRA
- Stock Information
- Founded
- HSCS 2007
- NDRA 2007
- Country
- HSCS United States
- NDRA United States
- Employees
- HSCS N/A
- NDRA N/A
- Industry
- HSCS Medical Specialities
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HSCS Health Care
- NDRA Health Care
- Exchange
- HSCS Nasdaq
- NDRA Nasdaq
- Market Cap
- HSCS 3.2M
- NDRA 3.0M
- IPO Year
- HSCS 2022
- NDRA 2017
- Fundamental
- Price
- HSCS $3.17
- NDRA $5.05
- Analyst Decision
- HSCS Strong Buy
- NDRA Strong Buy
- Analyst Count
- HSCS 2
- NDRA 1
- Target Price
- HSCS $13.50
- NDRA $14,000.00
- AVG Volume (30 Days)
- HSCS 15.1K
- NDRA 20.1K
- Earning Date
- HSCS 03-13-2025
- NDRA 03-27-2025
- Dividend Yield
- HSCS N/A
- NDRA N/A
- EPS Growth
- HSCS N/A
- NDRA N/A
- EPS
- HSCS N/A
- NDRA N/A
- Revenue
- HSCS $14,700.00
- NDRA N/A
- Revenue This Year
- HSCS $174.19
- NDRA N/A
- Revenue Next Year
- HSCS $4,100.00
- NDRA N/A
- P/E Ratio
- HSCS N/A
- NDRA N/A
- Revenue Growth
- HSCS 151.28
- NDRA N/A
- 52 Week Low
- HSCS $2.36
- NDRA $4.01
- 52 Week High
- HSCS $18.50
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- HSCS 39.08
- NDRA 42.27
- Support Level
- HSCS $3.11
- NDRA $4.68
- Resistance Level
- HSCS $3.45
- NDRA $5.65
- Average True Range (ATR)
- HSCS 0.17
- NDRA 0.45
- MACD
- HSCS -0.02
- NDRA -0.09
- Stochastic Oscillator
- HSCS 8.70
- NDRA 20.37
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.